Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLR250 versus Dianeal PD-4 in chronic renal failure patients on CAPD in Japan
ISRCTN10007426Phase 3Completed
- Sponsor
- Baxter International Inc.
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of BLR250 and Dianeal PD4 in chronic kidney disease (CKD), sponsored by Baxter International Inc. Primary endpoints: Peritoneal creatinine clearance and Ultrafiltration volume. Started Mar 2003; status: completed.
02
Drugs
BLR250Dianeal PD4
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ISRCTN10007426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10007426.